HTGMQ (HTG Molecular Diagnostics) ROE % Adjusted to Book Value: -54.88% (As of Mar. 2023)


HTGMQ HTG Molecular Diagnostics Inc HTGMQ
12 GF Score
Price $0.00
View Full Analysis

What is HTG Molecular Diagnostics ROE % Adjusted to Book Value?

HTG Molecular Diagnostics HTGMQ 12 ROE % Adjusted to Book Value is -54.88% as of Mar. 2023. GuruFocus rates HTGMQ with a GF Score™ of 12/100.

HTG Molecular Diagnostics's ROE % for the quarter that ended in Mar. 2023 was -689.28%. HTG Molecular Diagnostics's PB Ratio for the quarter that ended in Mar. 2023 was 12.56. HTG Molecular Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was -54.88%.

HTG Molecular Diagnostics ROE % Adjusted to Book Value Related Terms

HTG Molecular Diagnostics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for HTG Molecular Diagnostics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HTG Molecular Diagnostics ROE % Adjusted to Book Value Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.90 -50.38 -63.10 -34.88 -166.76

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -226.33 -137.13 -95.01 -346.86 -54.88

HTGMQ vs ABMC, TMO, DHR: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's ROE % Adjusted to Book Value falls into.


HTGMQ
12GF Score
HTG Molecular Diagnostics Inc HTGMQ
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HTG Molecular Diagnostics ROE % Adjusted to Book Value Calculation

HTG Molecular Diagnostics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-273.48% / 1.64
=-166.76%

HTG Molecular Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-689.28% / 12.56
=-54.88%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -54.88% mean?
HTG Molecular Diagnostics (HTGMQ) has a ROE % Adjusted to Book Value of -54.88% as of Mar. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on HTG Molecular Diagnostics and its competitors.
Is HTG Molecular Diagnostics' ROE % Adjusted to Book Value too high?
HTG Molecular Diagnostics' current ROE % Adjusted to Book Value is -54.88%. Overall, HTG Molecular Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HTG Molecular Diagnostics' ROE % Adjusted to Book Value compare to ABMC and TMO?
HTG Molecular Diagnostics' ROE % Adjusted to Book Value of -54.88% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on HTG Molecular Diagnostics and its competitors. HTG Molecular Diagnostics's current ROE % Adjusted to Book Value is -54.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HTG Molecular Diagnostics stock overvalued right now?
HTG Molecular Diagnostics (HTGMQ) has a current ROE % Adjusted to Book Value of -54.88%. The current ROE % Adjusted to Book Value is -54.88%. HTG Molecular Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For HTG Molecular Diagnostics (HTGMQ), the current ROE % Adjusted to Book Value is -54.88% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HTG Molecular Diagnostics Business Description

Address 3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
12GF Score

Get the complete analysis for HTGMQ

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price